RNA-sequencing identifies novel transcriptomic signatures in intestinal failure-associated liver disease

Transcriptomic analysis of TPN-induced liver disease in rats identifies ferroptosis pathways and Slc7a11 upregulation as key molecular signatures. The transcription factor Hes6 emerges as a potential therapeutic target, correlating with bile acid profiles and hepatic triglyceride levels in IFALD pathogenesis.